Methimazole Initial Dose
For adults with overt Graves' hyperthyroidism, start methimazole at 10-20 mg once daily, with 15 mg daily being the optimal initial dose for most patients.
Dosing Algorithm Based on Disease Severity
The initial methimazole dose should be tailored to hyperthyroidism severity 1, 2:
- Mild hyperthyroidism: 10-15 mg daily
- Moderate hyperthyroidism: 15-20 mg daily
- Severe hyperthyroidism (free T4 >2-3× upper limit of normal, extremely symptomatic): 30-40 mg daily, divided into doses if needed
The 15 mg once-daily starting dose represents the best balance between efficacy and safety 1, 3. This recommendation is supported by both the 2011 ATA/AACE guidelines stating "higher doses are advised (10-20 mg daily)" 1 and the FDA label indicating 15 mg for mild disease 2.
Critical Safety Consideration
Starting with 15 mg daily rather than 30 mg daily significantly reduces the risk of agranulocytosis - the most dangerous complication of methimazole therapy. A large retrospective study of 4,826 patients demonstrated that agranulocytosis occurred in 0.814% of patients started on 30 mg daily versus only 0.219% with 15 mg daily (p<0.01) 3. The combined rate of agranulocytosis plus neutropenia was 1.581% versus 0.474% respectively (p<0.001) 3.
Practical Implementation
Administer as a single daily dose - methimazole's pharmacokinetics allow once-daily dosing, which improves adherence and reduces side effects compared to divided doses 4, 1. Studies confirm that 15 mg once daily achieves euthyroidism as rapidly as conventional divided dosing (10 mg three times daily), with mean time to euthyroidism of approximately 5-6 weeks in both regimens 5, 6.
When to Use Higher Initial Doses
Reserve 30-40 mg daily for patients with:
- Free T4 levels 2-3 times the upper limit of normal
- Severe symptomatic hyperthyroidism
- Cardiovascular complications requiring rapid control 1, 2
Even in severe cases, consider starting at 15-20 mg with close monitoring rather than automatically using 30+ mg, given the dose-dependent toxicity risk 3.
Titration Strategy
After achieving euthyroidism (typically 4-8 weeks), gradually reduce to a maintenance dose of 5-10 mg daily 1. Recent evidence suggests that patients with initially severe disease may require more frequent monitoring during titration, as they experience more thyroid status lability despite reaching euthyroidism at similar rates 7.
Common Pitfall to Avoid
Do not use "block and replace" therapy (high-dose methimazole plus levothyroxine) as routine treatment - this approach increases adverse effects without improving outcomes 1.
Baseline Monitoring
Before initiating therapy, obtain baseline complete blood count with differential and liver function tests (transaminases, bilirubin) 1. This allows interpretation of future values, as hyperthyroidism itself can cause abnormal liver enzymes and autoimmune conditions may cause baseline leukopenia.